2020 annual financial data
BioCryst Pharmaceuticals 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -770.36%.
Operating income was -174,757,000 USD and net income was -182,814,000 USD.
Operating cash flow was -137,216,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,812,000 USD
- Operating income
- -174,757,000 USD
- Net income
- -182,814,000 USD
- Operating cash flow
- -137,216,000 USD